DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
EXTAVIA*SC 15FL 250MCG/ML+15SI ( DrugBank: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
13
多発性硬化症/視神経脊髄炎
1
13. 多発性硬化症/視神経脊髄炎
臨床試験数
:
3,342
/
薬物数
:
2,355
- (
DrugBank
:
406
) /
標的遺伝子数
:
269
-
標的パスウェイ数
:
241
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2010-023677-19-IT
(
EUCTR
)
23/03/2011
10/06/2011
Bio-molecular effects of interferon-beta and d-vitamin association - VITAD-2010
Bio-molecular effects of interferon-beta and d-vitamin association - VITAD-2010
PATIENT WITH RRMS AND SPMS
MedDRA version: 13.1;Level: HLT;Classification code 10052785;Term: Multiple sclerosis acute and progressive;System Organ Class: 10029205 - Nervous system disorders
PATIENT WITH RRMS AND SPMS
MedDRA version: 13.1;Level: HLT;Classification code 10052785;Term: Multip ...
Trade Name: BETAFERON*15CONFEZ 0,25MG/ML+
INN or Proposed INN: Interferon beta-1b
Trade Name:
EXTAVIA*SC 15FL 250MCG/ML+15SI
INN or Proposed INN: Interferon beta-1b
Trade Name: DIBASE
INN or Proposed INN: Colecalciferol
Trade Name: BETAFERON*15CONFEZ 0,25MG/ML+
INN or Proposed INN: Interferon beta-1b
Trade Name:
EXTAVIA*
...
AZIENDA OSPEDALIERA S. LUIGI GONZAGA
NULL
Authorised-recruitment may be ongoing or finished
Female: yes
Male: yes
Italy